News About: Pharm. Industry
Is Pfizer neglecting recall of defected Caverject injection?
Pharmaceutical giant Pfizer is accused of its failure in recalling about 81 lots of anti-impotence shot Caverject because of the potential for defective needles, inviting criticism from domestic pharmacists.
The ac...
Pharmaceutical firms reluctant to spend on R&D
A total of 30 pharmaceutical companies that chalked up the combined sales of over 3.8 trillion won for the first half of this year, invested 240.3 billion won in research, an average 6.3 percent of their revenue.
Y...
Drug makers’ first-half promotional expenses declined
Two out of five Korean pharmaceutical firms slashed their promotional expenses by more than 30 percent in the first half of this year due to the government’s policy to abandon “rebates” ― a kind of kickback given by d...
Drug-price cut fiasco
Pharmaceutical firms are at a loss as to why the government is pushing ahead with the unreasonable policy, which will result in 2 trillion won in losses for the pharmaceutical industry.
On August 12, the government...
First intradermal influenza vaccine to be released
Sanofi-Pasteur Korea and Handok Pharmaceutical plan to launch IDflu 15 μg㎍ vaccine, the first intradermal (ID) microinjection influenza vaccine, from next month.
Vaccination via the ID route involves the administra...
7 drugmakers has 27 blockbuster drugs exceeding 10 billion won in first half
A total of 27 flagship products released by seven leading Korean drug firms recorded more than 10 billion won in the first-half sales, according to data released by Yakup.com.
The data showed that Dong-A Pharmaceut...
More tax exemptions set for R&D spending
Starting from next March, the government seeks to expand tax exemptions for corporate investment in research and development (R&D) as part of efforts to stimulate state-run and private companies’ R&D spending in the e...
Dong-A raises prices of Bayer’s OTC drugs
Dong-A Pharmaceutical Co. says it will significantly increase the prices of eight over-the-counter (OTC) products produced by Bayer between 13 and 30 percent to seek its profitable co-marketing business.
The compan...
Pharmaceutical firms spend 35.4% on promotion in first half
These days marketing activities have shrunken as the government expresses its strong will to punish both distributors and medical personnel if the latter is found to have received a “rebate” or kickback while purchasi...
Per capital sales of drug firms top 155 million won on average
Per capita revenues of 30 pharmaceutical firms posted an average 155 million won in the first half of this year, according to Yakup.com.
The website’s latest data on the revenues of these pharmaceutical companies l...
